Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Kavallaris

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2007
A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenograftsVivienna Ong, Natalia L M Liem, Michael A Schmid, et al.
Cancer Medicine|August 10, 2022
βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cellsSimon Brayford, Alastair Duly, Wee Siang Teo, et al.
ACS Nano|October 18, 2013
Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin releaseJohan S Basuki, Hien T T Duong, Alexander Macmillan, et al.
Cancer Letters|January 17, 2009
The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylationAnna Raif, Glenn M Marshall, Jessica L Bell, et al.
Journal of the National Cancer Institute|October 5, 2006
Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemiaNicole M Verrills, Sela T Po'uha, Marjorie L M Liu, et al.
Cell Communication and Signaling : CCS|June 10, 2025
Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cellsRosa Mistica C Ignacio, Helen Forgham, Zerong Ma, et al.
Molecular Pharmaceutics|April 25, 2013
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymersCyrille Boyer, Joann Teo, Phoebe Phillips, et al.
Oncotarget|July 5, 2016
Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growthOrazio Vittorio, Miriam Brandl, Giuseppe Cirillo, et al.
Drug Delivery and Translational Research|February 18, 2026
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2Yuan Zhang, Matt D Johansen, Scott Ledger, et al.
International Journal of Cancer|February 8, 2007
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulinsStefania Tommasi, Anita Mangia, Rosanna Lacalamita, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Pharmacology and Experimental Therapeutics|November 8, 2007
A role for altered microtubule polymer levels in vincristine resistance of childhood acute lymphoblastic leukemia xenograftsVivienna Ong, Natalia L M Liem, Michael A Schmid, et al.
Cancer Medicine|August 10, 2022
βIII-tubulin suppression enhances the activity of Amuvatinib to inhibit cell proliferation in c-Met positive non-small cell lung cancer cellsSimon Brayford, Alastair Duly, Wee Siang Teo, et al.
ACS Nano|October 18, 2013
Using fluorescence lifetime imaging microscopy to monitor theranostic nanoparticle uptake and intracellular doxorubicin releaseJohan S Basuki, Hien T T Duong, Alexander Macmillan, et al.
Cancer Letters|January 17, 2009
The estrogen-responsive B box protein (EBBP) restores retinoid sensitivity in retinoid-resistant cancer cells via effects on histone acetylationAnna Raif, Glenn M Marshall, Jessica L Bell, et al.
Journal of the National Cancer Institute|October 5, 2006
Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemiaNicole M Verrills, Sela T Po'uha, Marjorie L M Liu, et al.
Cell Communication and Signaling : CCS|June 10, 2025
Chemotherapy reprograms miRNA expression profiles in apoptotic extracellular vesicles from medulloblastoma cells, regulating pro- and anti-proliferative effects on recipient drug-naïve cellsRosa Mistica C Ignacio, Helen Forgham, Zerong Ma, et al.
Molecular Pharmaceutics|April 25, 2013
Effective delivery of siRNA into cancer cells and tumors using well-defined biodegradable cationic star polymersCyrille Boyer, Joann Teo, Phoebe Phillips, et al.
Oncotarget|July 5, 2016
Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growthOrazio Vittorio, Miriam Brandl, Giuseppe Cirillo, et al.
Drug Delivery and Translational Research|February 18, 2026
Comparative analysis of clinically approved lipid nanoparticles for intranasal siRNA delivery against SARS-CoV-2Yuan Zhang, Matt D Johansen, Scott Ledger, et al.
International Journal of Cancer|February 8, 2007
Cytoskeleton and paclitaxel sensitivity in breast cancer: the role of beta-tubulinsStefania Tommasi, Anita Mangia, Rosanna Lacalamita, et al.
Pageof 16